Caring Brands (CABR) Gross Margin (2024 - 2025)
Caring Brands' (CABR) quarterly Gross Margin came in at 54.48% in Q4 2025, up 40007.0% year-on-year from N/an in Q4 2024, and down 10.02% quarter-over-quarter from 60.54% in Q3 2025.
Caring Brands (CABR) Gross Margin (2024 - 2025) Analysis & Trends
Caring Brands' Gross Margin history runs 2 years deep, the most recent figure standing at 54.48% for Q4 2025.
- On a quarterly basis, Gross Margin rose 40007.0% year-over-year to 54.48% in Q4 2025; TTM through Dec 2025 was 11.64%, a N/A change from a year earlier, with the FY2025 full-year figure at 55.56%, changed N/A from the prior year.
- Gross Margin declined to 54.48% in Q4 2025 per CABR's latest filing, from 60.54% in the prior quarter.
- Across five years, Gross Margin topped out at 60.54% in Q3 2025 and bottomed at 345.59% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.48% |
| Sep 30, 2025 | 60.54% |
| Mar 31, 2025 | 53.85% |
| Dec 31, 2024 | -345.59% |